PNC Financial Services Group
NMTR

PNC Financial Services Group’s 9 Meters Biopharma NMTR Stock Holding History

PNC Financial Services Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150
Closed -$101 – 4830
2023
Q2 		$101 Hold
150
– – ﹤0.01% 4695
2023
Q1 		$209 Hold
150
– – ﹤0.01% 4596
2022
Q4 		$189 Hold
150
– – ﹤0.01% 4643
2022
Q3 		$1K Hold
150
– – ﹤0.01% 4379
2022
Q2 		$1K Hold
150
– – ﹤0.01% 4407
2022
Q1 		$2K Hold
150
– – ﹤0.01% 4260
2021
Q4 		$3K Hold
150
– – ﹤0.01% 4106
2021
Q3 		$4K Hold
150
– – ﹤0.01% 4013
2021
Q2 		$3K Hold
150
– – ﹤0.01% 4004
2021
Q1 		$4K Buy
+150
New +$4.61K ﹤0.01% 3883

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

PNC Financial Services Group's NMTR Position: Q3 2023 in Review

PNC Financial Services Group sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 150 shares — an estimated $101 sold.

PNC Financial Services Group first reported a position in NMTR in Q1 2021 and held it in 10 quarters. The position peaked at $4K in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • PNC Financial Services Group reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 150 9 Meters Biopharma shares in Q3 2023, an estimated $101.
  • PNC Financial Services Group first reported a position in 9 Meters Biopharma in Q1 2021 and held it in 10 quarters.
  • PNC Financial Services Group's 9 Meters Biopharma position peaked at $4K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on PNC Financial Services Group's 13F filing for Q3 2023, filed 13 Nov 2023.